120 related articles for article (PubMed ID: 25065703)
1. Successful treatment with reduced-intensity cord blood transplant in a patient with relapsed refractory hepatosplenic T-cell lymphoma.
Sumi M; Takeda W; Kaiume H; Kirihara T; Kurihara T; Sato K; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Kobayashi H
Leuk Lymphoma; 2015 Apr; 56(4):1140-2. PubMed ID: 25065703
[No Abstract] [Full Text] [Related]
2. Allogeneic transplantation for hepatosplenic alphabeta T-cell lymphoma.
Mansour MR; Dogan A; Morris EC; Khwaja A; Linch DC; Mackinnon S; Peggs KS
Bone Marrow Transplant; 2005 May; 35(9):931-4. PubMed ID: 15778731
[No Abstract] [Full Text] [Related]
3. Successful treatment of hepatosplenic T cell lymphoma in an adolescent with Turner syndrome using ifosfamide, carboplatin, and etoposide followed by allogeneic hematopoietic stem cell transplant.
Lauhan CR; Schiff D; Gloude N
Pediatr Blood Cancer; 2020 Nov; 67(11):e28528. PubMed ID: 32776434
[No Abstract] [Full Text] [Related]
4. Gastroenterology: Hepatosplenic T cell lymphoma associated with schistosomiasis.
Azevedo P; Pedrosa MS; Resende V
J Gastroenterol Hepatol; 2015 Sep; 30(9):1333. PubMed ID: 26211690
[No Abstract] [Full Text] [Related]
5. Incidence, clinical findings, and survival of hepatosplenic T-cell lymphoma in the United States.
Durani U; Go RS
Am J Hematol; 2017 Jun; 92(6):E99-E101. PubMed ID: 28263402
[No Abstract] [Full Text] [Related]
6. Hepatosplenic γ-δ T-Cell Lymphoma: Who Is on Your Speed Dial?
Krishnan M; Lunning M
J Oncol Pract; 2019 Jun; 15(6):307-312. PubMed ID: 31185190
[TBL] [Abstract][Full Text] [Related]
7. Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases.
Lu CL; Tang Y; Yang QP; Wang M; Zhao S; Bi CF; Jiang NG; Zhang WY; Liu JP; Xu X; Liu WP
Hum Pathol; 2011 Dec; 42(12):1965-78. PubMed ID: 21683978
[TBL] [Abstract][Full Text] [Related]
8. Umbilical cord blood transplantation induces a durable remission in hepatosplenic gamma-delta T cell lymphoma with associated hemophagocytic lymphohistiocytosis.
Ayala E; Chalhoub J; Kharfan-Dabaja MA
Am J Hematol; 2014 Sep; 89(9):934-5. PubMed ID: 24861697
[No Abstract] [Full Text] [Related]
9. Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma.
Ooi J; Iseki T; Adachi D; Yamashita T; Tomonari A; Tojo A; Tani K; Asano S
Haematologica; 2001 Oct; 86(10):E25. PubMed ID: 11602432
[No Abstract] [Full Text] [Related]
10. Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.
Honda T; Yamaoka M; Terao YM; Hasegawa D; Kumamoto T; Takagi M; Yoshida K; Ogawa S; Goto H; Akiyama M
Int J Hematol; 2022 Jan; 115(1):140-145. PubMed ID: 34591292
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma.
He S; Roberts A; Ritchie D; Grigg A
Leuk Lymphoma; 2007 Jul; 48(7):1448-50. PubMed ID: 17613781
[No Abstract] [Full Text] [Related]
12. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation.
Sakai R; Fujisawa S; Fujimaki K; Kanamori H; Ishigatsubo Y
Bone Marrow Transplant; 2006 Mar; 37(5):537-8. PubMed ID: 16415891
[No Abstract] [Full Text] [Related]
13. Hepatosplenic lymphoma presenting initially as hemophagocytic syndrome in a 21-year-old man with Crohn's disease: a case report and literature review.
Côté-Daigneault J; Bernard EJ
Can J Gastroenterol; 2011 Aug; 25(8):417-8. PubMed ID: 21912765
[No Abstract] [Full Text] [Related]
14. Hepatosplenic gamma-delta T-cell lymphoma.
Ferreri AJ; Govi S; Pileri SA
Crit Rev Oncol Hematol; 2012 Aug; 83(2):283-92. PubMed ID: 22047938
[TBL] [Abstract][Full Text] [Related]
15. Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant.
Bašić Kinda S; Duraković N; Dotlić S; Serventi Seiwerth R; Davidović Mrsić S; Dubravčić K; Aurer I
Leuk Lymphoma; 2013 Jun; 54(6):1334-5. PubMed ID: 23083012
[No Abstract] [Full Text] [Related]
16. Pralatrexate-based therapy induced response in an adolescent with refractory hepatosplenic T-cell lymphoma.
Dhir A; Hill B; Waite ES; Cairo MS; Xavier AC
Pediatr Blood Cancer; 2020 Nov; 67(11):e28460. PubMed ID: 32860655
[No Abstract] [Full Text] [Related]
17. Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation, and early hematopoietic stem cell transplant.
Schafer E; Chen A; Arceci RJ
Pediatr Blood Cancer; 2009 Dec; 53(6):1127-9. PubMed ID: 19479793
[TBL] [Abstract][Full Text] [Related]
18. Hepatosplenic T-cell lymphoma and TNF-α inhibitors.
Pozadzides JV; Pro B
Expert Rev Hematol; 2009 Dec; 2(6):611-4. PubMed ID: 21082951
[No Abstract] [Full Text] [Related]
19. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.
Yabe M; Medeiros LJ; Tang G; Wang SA; P Patel K; Routbort M; Bhagat G; Bueso-Ramos CE; Jorgensen JL; Luthra R; Chen W; Muzzafar T; Kanagal-Shamanna R; Khoury JD; Daneshbod Y; Davanlou M; Li S; Young KH; Miranda RN
Hum Pathol; 2016 Apr; 50():109-17. PubMed ID: 26997444
[TBL] [Abstract][Full Text] [Related]
20. Hepatosplenic γδ T-cell lymphoma of two adolescents: Case report and retrospective literature review in children, adolescents, and young adults.
McThenia SS; Rawwas J; Oliveira JL; Khan SP; Rodriguez V
Pediatr Transplant; 2018 Aug; 22(5):e13213. PubMed ID: 29921021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
